Administration of TNF-α neutralizing antibody to patients with type 2 diabetes does not reduce their insulin resistance (30, 31), suggesting that the inflammatory process could be a result of obesity, but not a cause of insulin resistance or diabetes. The gene discussed is TNF; the disease is obesity due to melanocortin 4 receptor deficiency.